Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is a rapidly
emerging pathogen with potentially serious consequences for public health. Here we …

Effective prophylaxis and antiviral therapies are urgently needed in the event of
reemergence of the highly contagious and often fatal severe acute respiratory syndrome …

Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …

The spike (S) glycoprotein of coronaviruses mediates viral entry into host cells. It is a type 1
viral fusion protein that characteristically contains two heptad repeat regions, denoted HR-N …

Severe acute respiratory syndrome coronavirus (SARS-CoV) is a recently identified human
coronavirus. The extremely high homology of the viral genomic sequences between the …

The spike protein in SARS-CoV-2 (SARS-2-S) interacts with the human ACE2 receptor to
gain entry into a cell to initiate infection. Both Pfizer/BioNTech's BNT162b2 and Moderna's …

ABSTRACT A novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-
CoV), has recently been identified as the causative agent of severe acute respiratory …

Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused
by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is …

Spike (S) proteins, the defining projections of the enveloped coronaviruses (CoVs), mediate
cell entry by connecting viruses to plasma membrane receptors and by catalyzing …

The coronavirus spike glycoprotein is a class I membrane fusion protein with two
characteristic heptad repeat regions (HR1 and HR2) in its ectodomain. Here, we report the X …